Ubiquitination and de-ubiquitination: role in regulation of signaling by Toll-like receptors

被引:18
作者
Lowe, Emily L.
Doherty, Terence M.
Karahashi, Hisae
Arditi, Moshe
机构
[1] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
来源
JOURNAL OF ENDOTOXIN RESEARCH | 2006年 / 12卷 / 06期
关键词
de-ubiquitination; inflammation; innate immunity; Toll-like receptor; ubiquitin;
D O I
10.1179/096805106X118915
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling by Toll-like receptors (TLRs) has attracted accelerating attention over the past decade because of the central role of TLR signaling in both innate and adaptive immunity. In addition, TLR signaling is now increasingly implicated in a remarkably wide range of diseases that are either caused, or accompanied, by dysregulated inflammation. Much has been learned about the basic signaling framework and participants, as well as how signaling is turned off and fine-tuned. Here, we summarize key aspects of TLR signaling, focusing on interaction with the anti-inflammatory TGF-beta signaling network. We propose that ubiquitination and de-ubiquitination of TLR pathway components may be a mechanism by which predominantly anti-inflammatory input is integrated into the host response to fine-tune inflammation in accordance with the needs of host defenses.
引用
收藏
页码:337 / 345
页数:9
相关论文
共 85 条
[11]   Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor [J].
Burns, K ;
Clatworthy, J ;
Martin, L ;
Martinon, F ;
Plumpton, C ;
Maschera, B ;
Lewis, A ;
Ray, K ;
Tschopp, J ;
Volpe, F .
NATURE CELL BIOLOGY, 2000, 2 (06) :346-351
[12]   Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[13]   Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors [J].
Chuang, TH ;
Ulevitch, RJ .
NATURE IMMUNOLOGY, 2004, 5 (05) :495-502
[14]   Toll-like receptors in the pathogenesis of human disease [J].
Cook, DN ;
Pisetsky, DS ;
Schwartz, DA .
NATURE IMMUNOLOGY, 2004, 5 (10) :975-979
[15]   Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain [J].
Deng, L ;
Wang, C ;
Spencer, E ;
Yang, LY ;
Braun, A ;
You, JX ;
Slaughter, C ;
Pickart, C ;
Chen, ZJ .
CELL, 2000, 103 (02) :351-361
[16]   TRAIL-R as a negative regulator of innate immune cell responses [J].
Diehl, GE ;
Yue, HH ;
Hsieh, K ;
Kuang, AA ;
Ho, M ;
Morici, LA ;
Lenz, LL ;
Cado, D ;
Riley, LW ;
Winoto, A .
IMMUNITY, 2004, 21 (06) :877-889
[17]   Negative receptor signalling [J].
Dikic, I ;
Giordano, S .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :128-135
[18]   TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis [J].
Doherty, Terence M. ;
Fisher, Edward A. ;
Arditi, Moshe .
TRENDS IN IMMUNOLOGY, 2006, 27 (05) :222-227
[19]   TB, or not TB: that is the question - does TLR signaling hold the answer? [J].
Doherty, TM ;
Arditi, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1699-1703
[20]   New insights into the post-translational modification of Toll-like receptor signaling molecules [J].
Dunne, A ;
O'Neill, L .
JOURNAL OF ENDOTOXIN RESEARCH, 2005, 11 (06) :325-332